Inso Biosciences is focused on revolutionizing biological sample preparation through its innovative microfluidic technology. The company aims to address the challenges associated with traditional sample preparation methods, which are often labor-intensive, slow, and prone to errors such as sample loss and variability. By developing high-precision automated solutions, Inso Biosciences seeks to enhance the quality and consistency of DNA extraction, ensuring that the correct fragment sizes are obtained while maintaining sample purity. Their platform is designed to streamline the sample preparation process, allowing for unattended operation and significantly reducing both hands-on and total processing times.

The applications of Inso Biosciences' technology are diverse and impactful, particularly in the fields of long-read DNA sequencing, clinical pathogen processing, and multi-omic analysis. Their system is capable of extracting ultra-high molecular weight DNA from small to medium cellular samples, which is crucial for long-read sequencing. Additionally, the technology enables rapid purification and isolation of pathogens from clinical samples, facilitating timely diagnosis and treatment of infectious diseases. Furthermore, Inso Biosciences' platform allows for the simultaneous separation and analysis of DNA and RNA from the same cell samples, even at the single-cell level, thereby expanding the potential for comprehensive biological analysis.

United States

Inso Biosciences is an early-stage biotechnology company developing hardware platforms and tools for genomic sample handling. 

Our patented microfluidic technology, invented and developed at Cornell University, performs high-efficiency processing of cellular material, and we are exploring applications in long-read DNA extraction, multiomic sample processing, and pathogen surveillance.

To find out more, please visit our website:
www.inso.bio

To get in touch with us, please email:
contact@inso.bio

Inso Biosciences

Company Details